Researchers have taken a significant step toward what they call a “Raman genome” — a spectroscopic fingerprint of viral RNA ...
RNA fusions offer new drug targets and insights into disease mechanisms, but detecting them is difficult. Workflows that integrate different types of samples and analyses can help.
A new benchmark of pathway activity scoring methods in single-cell RNA-seq reveals that top-rank-window tools like AUCell and ...
Modern neurological disease treatment, particularly research into ALS (amyotrophic lateral sclerosis), has achieved ...
Annovis Bio is using an AI tool to speed up its FDA filing for buntanetap, a drug aimed at Alzheimer’s and Parkinson’s.
Cooking is not something that relies solely on intuition or years of experience; it is a clear science based on the laws of ...
Objective Cellular ageing of the immune system has been suggested to play a role in the pathogenesis of rheumatoid arthritis ...
Biotech and pharma organizations are adopting AI at rapid pace, focusing on R&D, and precision medicine. As challenges emerge ...
Qiagen launched QIAmini on September 24, 2026, and Qiagen stock was last at EUR 39.16 on the Frankfurt Stock Exchange on ...
Biology doesn't operate in silos, and neither should the AI representation of it. Quine is an early-stage research effort to ...
To develop gene therapy tools based on CRISPR-associated transposons (CASTs), it is essential to define how transposon ends are recognized and paired during transposition. Transposon 7 (Tn7)–like ...
Recent studies have described an ability of cancer cells to survive engagement of apoptotic pathways following chemical and therapeutic insults, challenging the prevailing model that caspase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results